Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 40 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 9803022

    Mesothelin domain-specific monoclonal antibodies and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  2. US 9802904

    Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  3. US 9801865

    Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  4. US 9804163

    Biomarkers for prostate cancer and methods for their detection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  5. US 9795662

    Vaccine comprising AMA1 and RON2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  6. US 9795665

    Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  7. US 9790261

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  8. US 9789162

    Systemic and local ex vivo gene therapy of the skeleton

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  9. US 9790473

    Human Ebola virus species and compositions and methods thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  10. US 9783590

    Variants of human taste receptor genes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  11. US 9783787

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  12. US 9782399

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  13. US 9783586

    Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  14. US 9783595

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  15. US 9783579

    Compositions and methods for dengue virus chimeric constructs in vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  16. US 9783596

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  17. US 9782465

    Serologic correlates of protection against Bacillus anthracis infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  18. US 9775895

    HIV therapeutics and methods of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted

  19. US 9770405

    Biocompatible capsules and methods of making

    The United States of America as represented by the Administrator of NASA · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  20. US 9771428

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  21. US 9765342

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  22. US 9765063

    Amido compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  23. US 9765031

    Cannabinoid receptor mediating compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  24. US 9765142

    TEM8 antibodies and their use in treatment and detection of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.